Epstein-Barr Virus As a Leading Cause of Multiple Sclerosis: Mechanisms and Implications

Overview

Journal Nat Rev Neurol

Specialty Neurology

Date 2023 Feb 9

PMID 36759741

Authors

Kjetil Bjornevik

Christian Munz

Jeffrey I Cohen

Alberto Ascherio

Affiliations

Soon will be listed here.

Abstract

Epidemiological studies have provided compelling evidence that multiple sclerosis (MS) is a rare complication of infection with the Epstein-Barr virus (EBV), a herpesvirus that infects more than 90% of the global population. This link was long suspected because the risk of MS increases markedly after infectious mononucleosis (symptomatic primary EBV infection) and with high titres of antibodies to specific EBV antigens. However, it was not until 2022 that a longitudinal study demonstrated that MS risk is minimal in individuals who are not infected with EBV and that it increases over 30-fold following EBV infection. Over the past few years, a number of studies have provided clues on the underlying mechanisms, which might help us to develop more targeted treatments for MS. In this Review, we discuss the evidence linking EBV to the development of MS and the mechanisms by which the virus is thought to cause the disease. Furthermore, we discuss implications for the treatment and prevention of MS, including the use of antivirals and vaccines.

Citing Articles

Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis.

Qi C, Wang Y, Li X, Zheng C, Gu Y, Hu J J Neuroinflammation. 2025; 22(1):80.

PMID: 40082912 PMC: 11907836. DOI: 10.1186/s12974-025-03407-5.

Adapting systems biology to address the complexity of human disease in the single-cell era.

Fischer D, Villanueva M, Winter P, Shalek A Nat Rev Genet. 2025; .

PMID: 40065155 DOI: 10.1038/s41576-025-00821-6.

The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognition.

Trunfio M, Scutari R, Fox V, Vuaran E, Dastgheyb R, Fini V bioRxiv. 2025; .

PMID: 40060671 PMC: 11888432. DOI: 10.1101/2025.02.28.640732.

Role of innate immune cells in multiple sclerosis.

Prado C, Herrada A, Hevia D, Goiry L, Escobedo N Front Immunol. 2025; 16:1540263.

PMID: 40034690 PMC: 11872933. DOI: 10.3389/fimmu.2025.1540263.

Deep learning enhances the prediction of HLA class I-presented CD8 T cell epitopes in foreign pathogens.

Wohlwend J, Nathan A, Shalon N, Crain C, Tano-Menka R, Goldberg B Nat Mach Intell. 2025; 7(2):232-243.

PMID: 40008296 PMC: 11847706. DOI: 10.1038/s42256-024-00971-y.

References

Murray J . Infection as a cause of multiple sclerosis. BMJ. 2002; 325(7373):1128. PMC: 1124624. DOI: 10.1136/bmj.325.7373.1128. View

Cook S . Multiple sclerosis. Arch Neurol. 1998; 55(3):421-3. DOI: 10.1001/archneur.55.3.421. View

Kurtzke J . An epidemiologic approach to multiple sclerosis. Arch Neurol. 1966; 14(2):213-22. DOI: 10.1001/archneur.1966.00470080097015. View

Gale C, Martyn C . Migrant studies in multiple sclerosis. Prog Neurobiol. 1995; 47(4-5):425-48. View

Kurtzke J, Heltberg A . Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol. 2001; 54(1):1-22. DOI: 10.1016/s0895-4356(00)00268-7. View

Kurtzke J, Gudmundsson K, Bergmann S . Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Neurology. 1982; 32(2):143-50. DOI: 10.1212/wnl.32.2.143. View

Bray P, Bloomer L, Salmon V, Bagley M, Larsen P . Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol. 1983; 40(7):406-8. DOI: 10.1001/archneur.1983.04050070036006. View

Larsen P, Bloomer L, Bray P . Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology. 1985; 35(3):435-8. DOI: 10.1212/wnl.35.3.435. View

Sumaya C, Myers L, Ellison G . Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol. 1980; 37(2):94-6. DOI: 10.1001/archneur.1980.00500510052009. View

10.

Thacker E, Mirzaei F, Ascherio A . Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006; 59(3):499-503. DOI: 10.1002/ana.20820. View

11.

DeLorenze G, Munger K, Lennette E, Orentreich N, Vogelman J, Ascherio A . Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol. 2006; 63(6):839-44. DOI: 10.1001/archneur.63.6.noc50328. View

12.

Levin L, Munger K, Rubertone M, Peck C, Lennette E, Spiegelman D . Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005; 293(20):2496-500. DOI: 10.1001/jama.293.20.2496. View

13.

Munger K, Levin L, OReilly E, Falk K, Ascherio A . Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler. 2011; 17(10):1185-93. PMC: 3179777. DOI: 10.1177/1352458511408991. View

14.

Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L . An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology. 2004; 62(12):2277-82. DOI: 10.1212/01.wnl.0000130496.51156.d7. View

15.

Nielsen T, Rostgaard K, Nielsen N, Koch-Henriksen N, Haahr S, Soelberg Sorensen P . Multiple sclerosis after infectious mononucleosis. Arch Neurol. 2007; 64(1):72-5. DOI: 10.1001/archneur.64.1.72. View

16.

Jacobs B, Giovannoni G, Cuzick J, Dobson R . Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler. 2020; 26(11):1281-1297. PMC: 7543008. DOI: 10.1177/1352458520907901. View

17.

Dobson R, Kuhle J, Middeldorp J, Giovannoni G . Epstein-Barr-negative MS: a true phenomenon?. Neurol Neuroimmunol Neuroinflamm. 2017; 4(2):e318. PMC: 5292929. DOI: 10.1212/NXI.0000000000000318. View

18.

Abrahamyan S, Eberspacher B, Hoshi M, Aly L, Luessi F, Groppa S . Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020; 91(7):681-686. PMC: 7361012. DOI: 10.1136/jnnp-2020-322941. View

19.

Bjornevik K, Cortese M, Healy B, Kuhle J, Mina M, Leng Y . Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022; 375(6578):296-301. DOI: 10.1126/science.abj8222. View

20.

BURKITT D . A sarcoma involving the jaws in African children. Br J Surg. 1958; 46(197):218-23. DOI: 10.1002/bjs.18004619704. View